Drugs / human amniotic epithelial cells
human amniotic epithelial cells
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02912104 | Jun 2020 → Jan 2022 | infertility disorder, primary ovarian failure | International Peace Maternity and Child Health Hospital | Completed | No outcome recorded |
| Phase 1 | NCT03107975 | Apr → Dec 2017 | spastic cerebral palsy | The Second Affiliated Hospital of Fujian Medical University | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03031509 | Dec 2017 → Mar 2018 | — | Shanghai East Hospital | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human amniotic epithelial cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03107975 ↗ |
| Known as | hAEC | “human amniotic epithelial cell (hAEC) transplant” NCT03107975 ↗ |
| Known as | hAECs | “human amniotic epithelial cells (hAECs) transplantation” NCT02912104 ↗ |
| Modality | Cell therapy | “Human Amniotic Epithelial Cells transplant” NCT03031509 ↗ |
| Route | Other | “injected into ovarian tissue by bilateral ovarian artery infusion” NCT02912104 ↗ |